S-1

Company

Aspire Biopharma Holdings, Inc.

Filed

February 17, 2026

Accession Number

0001493152-26-007123

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →